ATL1103 Phase II trial results published in leading journal
Filed with ASX · · 2 pages · English
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Response to ASX Price & Volume Query
- $5 Million Capital Raising Completion
- Entitlement Offer Booklet
- Placement Completion and Entitlement Issue
- Institutional Placement and Rights Issue
Later from Percheron Therapeutics
- ATL1103/atesidorsen Early Access Program Progress Update
- ANP initiates ATL1102 Phase II clinical trial in DMD
- First Patient Dosed in Phase II DMD Clinical Trial
- Full Year Statutory Accounts
- Response to ASX Price and Volume Query
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics